USANA PALMETTO+ CAPSULE
USANA PALMETTO+ CAPSULE : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
- Registration number
- MAL14055107T
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- UHS ESSENTIAL HEALTH (MALAYSIA) SDN. BHD.
- Manufacturer
- USANA HEALTH SCIENCES, INC
- Importer
- UHS ESSENTIAL HEALTH (MALAYSIA) SDN. BHD.
- Registration period starting
- 2024-05-11
- Published validity end
- 2029-05-11
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- Conditions légales
Glycine max. (L.) Merr.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Serenoa repens | Serenoa repens[330mg;855mg] | Not identified |
| Lycopersicon esculentum | Lycopersicon esculentum[74mg;855mg] | Not identified |
| GLYCINE MAX | GLYCINE MAX[64mg;855mg] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Active ingredients
- Serenoa repens[330mg;855mg],Lycopersicon esculentum[74mg;855mg],GLYCINE MAX[64mg;855mg]
- Valid until
- 2029-05-11
- Registration date
- 2024-05-11
- Published description
- NATURAL PRODUCT
- Licence holder
- UHS ESSENTIAL HEALTH (MALAYSIA) SDN. BHD.
- Importer
- UHS ESSENTIAL HEALTH (MALAYSIA) SDN. BHD.
- Producer
- USANA HEALTH SCIENCES, INC
- Published name
- USANA PALMETTO+ CAPSULE
- Published reference
- 201310102016T
- Registration number
- MAL14055107T
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL14055107T
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Serenoa repens
Read the warning, when it applies and the studies cited
SAW PALMETTO – SERENOA REPENS
Route of administration: Oral
Cautions and warnings
Condition of application: All subpopulations.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Adult males only.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to exclude a diagnosis of prostate cancer (USP-NF 2024; Mills and Bone 2005).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Adult females only.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking oral contraceptives or hormone replacement therapy (UpToDate 2024).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Condition of application: Adult females only.
Do not use if you are pregnant, breastfeeding, or attempting to conceive (UpToDate 2024).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
- GLYCINE MAX
Read the warning, when it applies and the studies cited
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.